TP53 LOSS CREATES SUSCEPTIBILITY TO ANTI-POL II THERAPY IN COLORECTAL CANCER

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2015年 / 5卷 / 06期
关键词：
D O I：
10.1158/2159-8290.CD-RW2015-083
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：577 / 577
页数：1
相关论文
共 50 条
  • [41] TP53 Codon 72 Polymorphism and the Risk of Colorectal Cancer in an Azerbaijani Population
    Yagublu, Vugar
    Bayramov, Bayram
    Yuce, Melek
    Aslanov, Hazi
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (06): : 485 - 490
  • [42] RAS, BRAF, and TP53 Gene Mutations in Taiwanese Colorectal Cancer Patients
    Chang, Ya-Sian
    Chang, Shun-Jen
    Yeh, Kun-Tu
    Lin, Tsai-Hsiu
    Chang, Jan-Gowth
    ONKOLOGIE, 2013, 36 (12): : 719 - 724
  • [43] TP53 CODON 72 POLYMORPHISM AND MICROSATELLITE INSTABILITY IN SPORADIC COLORECTAL CANCER
    Dastjerdi, Mehdi Nikbahkt
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3253 - 3253
  • [44] Mutations and polymorphisms in TP53 gene-an overview on the role in colorectal cancer
    Naccarati, A.
    Polakova, V.
    Pardini, B.
    Vodickova, L.
    Hemminki, K.
    Kumar, R.
    Vodicka, P.
    MUTAGENESIS, 2012, 27 (02) : 211 - 218
  • [45] APC and TP53 as potential biomarkers for EGFR sensitivity in colorectal cancer.
    Thota, Ramya
    Yang, Mingli
    Davis, Thomas
    Schell, Michael J.
    Pledger, Warren Jack
    Yeatman, Timothy Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [46] Prognostic Impact of TP53 Mutations and Tumor Mutational Load in Colorectal Cancer
    Ho, Vincent
    Chung, Liping
    Lim, Stephanie H.
    Ma, Yafeng
    Wang, Bin
    Lea, Vivienne
    Abubakar, Askar
    Ng, Weng
    Lee, Mark
    Roberts, Tara L.
    Chua, Wei
    Lee, C. Soon
    GASTROINTESTINAL DISORDERS, 2022, 4 (03): : 165 - 179
  • [47] A Primer on the Role of TP53 Mutation and Targeted Therapy in Endometrial Cancer
    Zhang, Bohao
    Zhang, Haozhe
    Qin, Yanru
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2025, 30 (01):
  • [48] Researchers combine TP53 gene therapy and chemotherapy in advanced cancer
    不详
    ONCOLOGY-NEW YORK, 1998, 12 (10): : 1517 - 1517
  • [49] CANCER THERAPY dMMR and thiopurines strand TP53 for ALL relapse
    Evensen, Nikki A.
    Carroll, William L.
    NATURE CANCER, 2021, 2 (08) : 777 - 779
  • [50] The tumor suppressor gene TP53: Implications for cancer management and therapy
    Seemann, S
    Maurici, D
    Olivier, M
    de Fromentel, CC
    Hainaut, P
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2004, 41 (5-6) : 551 - 583
12345